**Core tip:** Cystic lesions in the liver, such as intraductal papillary neoplasms of the bile duct, rarely yield malignant tumors; additionally, the development of a tumor over a decade is hardly ever observed. Here, we present the case of a patient with an intrahepatic intraductal papillary neoplasm of the bile duct that developed over 13 years from a cystic tumor of the liver. The tumor was diagnosed by contrast-enhanced ultrasonography with perfluorobutane and was completely surgically resected. Notably, the intracystic spread of the tumor was well represented by contrast-enhanced ultrasonography.

INTRODUCTION
============

Intraductal papillary neoplasm of the bile duct (IPNB) is a type of tumor that presents in the common or intrahepatic bile duct and occasionally accompanies mucus production\[[@B1]\]. IPNB shares common characteristics in common with intrapancreatic mucinous neoplasms (IPMNs), which are sometimes malignant\[[@B2]\]. Although the development of IPMNs from pancreatic cysts is well documented because of the high prevalence rate of these neoplasms, there are only a few reports about IPNB development from hepatic cysts. Careful follow-up for IPNB is recommended because complete and timely surgical resection is required if malignancy is suspected\[[@B3]\]. However, little is known about the natural course of IPNB over a long-term period.

The clinical diagnosis of the IPNB is often made by computed tomography (CT) or magnetic resonance imaging (MRI), however, few studies have reported that contrast-enhanced ultrasonography (CEUS) is useful for diagnosing the tumor. Here, we report a case of IPNB that developed in a normal liver over 13 years with follow-up imaging of hepatic cystic hepatic tumors. We could clearly detect papillary lesions and tumor progressions by CEUS and performed successful resection.

CASE PRESENTATION
=================

Chief complaints
----------------

A 65-year-old Japanese man was admitted for growing cystic tumors in his liver. Liver cysts were originally found 13 years prior.

History of present illness
--------------------------

Two cystic lesions, located in the right hepatic lobe with diameters of 6 (anterior tumor: Tumor-Ant) and 18 (posterior tumor: Tumor-Post) mm, were detected by primary imaging performed in 2004. Magnetic resonance imaging (MRI) demonstrated simple liver cysts; however, tumor-Post partially contained abnormal lesions (Figure [1](#F1){ref-type="fig"}). Because ultrasonography of tumor-Post demonstrated hyperechoic lesions, leading to the suspicion of solid tumors, ultrasound-guided histological puncture of tumor-Post was performed, and the result showed normal liver tissue with no malignancy ([Supplementary Figure 1](Supplementary Figure 1)). Biannual follow-up examinations were performed, because there is a possibility that the biopsy missed the target and the complex morphology of the cystic tumor had the potential for malignancy.

![Magnetic resonance imaging and ultrasonography were performed during the initial visit. A and B: Magnetic resonance imaging shows 2 tumors in the right lobe. Anterior tumor is 6 mm, with low intensity on the T1-weighted image (A) and high intensity on the T2-weighted image (B; white arrow), which is consistent with simple liver cysts. Posterior tumor is 18 mm with mostly T1 low- and T2 high-intensity areas but has partial T1 high- and T2 low-intensity areas (black arrow). C: B-mode ultrasonography of the posterior tumor shows low-echoic cystic lesions with high-echoic areas inside.](WJG-25-5569-g001){#F1}

In 2015, eleven years after the initial clinical visit, MRI demonstrated a 4 mm papillary lesion on the anterior surface of tumor-Ant for the first time. Tumor-Ant and tumor-Post had enlarged to 14 and 30 mm, respectively. From these findings, we diagnosed the tumor as IPNB and recommended surgical resection to the patient. Although the tumor had a potential for malignancy, the patient hoped to wait and see if the papillary tumor grew. Two years later, in 2017, tumor-Ant had enlarged to 33 mm, and new papillary lesions were present, so the patient underwent a detailed examination. The timeline of tumor proliferation is shown in Figure [2](#F2){ref-type="fig"}.

![Timeline of tumor proliferation.](WJG-25-5569-g002){#F2}

History of past illness
-----------------------

The patient had no previous noteworthy medical history.

Personal and family history
---------------------------

The patient did not smoke tobacco or consume alcohol. There was no noteworthy family medical history, such as cancer or liver diseases.

Physical examination
--------------------

The patient's height and weight were 162 cm and 59 kg, respectively. The patient exhibited a clear sensorium, with a body temperature of 37.0 °C, blood pressure of 120/52 mmHg, and pulse rate of 58 beats/min. The abdomen was soft and flat, with no spontaneous pain or tenderness.

Laboratory examinations
-----------------------

There were no abnormal laboratory data findings, including tumor marker results.

Imaging examinations
--------------------

The papillary lesion had grown to 8 mm with another new 9 mm papillary lesion on the posterior surface of tumor-Ant (Figure [3](#F3){ref-type="fig"}). No significant papillary hyper-enhancement was detected through dynamic CT or MRI studies.

![Computed tomography performed 13 years after the initial clinical visit. A and C: Plain computed tomography (CT) shows the 33 mm anterior tumor and the 32 mm posterior tumor. Two papillary proliferations are observed on the surface of the anterior tumor \[8 mm on the anterior surface (A; white arrow) and 9 mm on the posterior surface (C; black arrow)\]. B and D: Portal-phase CT shows slight hyperenhancement of the tumor surface and the papillary proliferation. CT: Computed tomography.](WJG-25-5569-g003){#F3}

CEUS using perfluorobutane (Sonazoid™; Daiichi-Sankyo, Japan) demonstrated papillary hyperenhancement and marginal hyperenhancement of tumor-Ant during the arterial phase. Moreover, marginal hyperenhancement of tumor-Post was demonstrated on CEUS, which indicated IPNB extension to tumor-Post (Figure [4](#F4){ref-type="fig"}). Although cystic-type IPNB usually has a connection between bile ducts, we could not detect a connection by magnetic resonance cholangiopancreatography or drip infusion cholecystocholangiography CT. Endoscopic retrograde cholan-giopancreatography was not performed because we could not obtain patient agreement for the procedure.

![Ultrasonography performed 13 years after the initial clinical visit. Contrast-enhanced ultrasonography shows a 7 mm hyperechoic papillary proliferation (A: Pre-enhancement; B: Arterial phase). Marginal hyperenhancement of the anterior tumor and early enhancement of the papillary proliferation were detected. Marginal enhancement of the posterior tumor (black arrows) was also detected, which suggests tumor spread to the posterior tumor.](WJG-25-5569-g004){#F4}

TREATMENT
=========

Because the papillary proliferation had grown, which indicated tumor malignancy, liver segment 8 subsegmentectomy was performed after the patient provided informed consent. The surgery procedure resulted in complete tumor resection. Cholangiography during the surgical procedure showed cystic pooling of the contrast media, demonstrating the connection between the bile ducts and cystic tumors (Figure [5](#F5){ref-type="fig"}) and suggesting that the cystic lesions should be considered IPNB but not mucinous cystic neoplasms.

![Cholangiography during the surgical procedure. Cholangiography showed cystic tumor enhancement (black arrows), which represents ductal communication between the cystic lesions and bile ducts.](WJG-25-5569-g005){#F5}

Pathological findings
---------------------

Macroscopically, tumor-Ant contained a mixture of mucin and bile, and tumor-Post contained solidified bile (Figure [6A](#F6){ref-type="fig"}). Microscopically, papillary proliferation of the gastric epithelium with high-grade nuclear atypia was observed at the posterior surface of tumor-Ant. Both tumor-Ant and tumor-Post showed proliferation of the tumor cells with high-grade dysplasia, which represented an IPNB extension on tumor-Post (Figure [6B](#F6){ref-type="fig"}). Thick band-like proliferation of the glandular epithelium of the papillary structure was observed on the posterior surface of tumor-Post, which corresponded to the hyperenhancement observed on CEUS (Figure [6C](#F6){ref-type="fig"}). No stromal invasion was detected. Immunohistochemical analysis demonstrated mucin core protein 5AC (MUC5AC) and MUC6 positivity in most cells. MUC2 was positive in less than 5% of the tumor cells, whereas MUC1 was negative (Figure [6D](#F6){ref-type="fig"}-[G](#F6){ref-type="fig"}), suggesting that the tumor is gastric type neoplasm.

![Pathological findings of the surgical specimens. A: Macroscopic findings show 2 cystic lesions with a maximum diameter of 3 cm. The anterior tumor (black arrowhead) contained mucin and bile with papillary proliferation, while the posterior tumor (white arrowhead) contained solidified bile. B: Microscopic findings of the tumor (yellow square in A). Dysplastic epithelium proliferated on both anterior tumor (black arrow) and posterior tumor (white arrow). Higher magnification of the papillary proliferation of the posterior tumor (yellow square in B) shows dysplastic epithelium. C: Thick glandular epithelium was observed on the posterior tumor (red square in B), which corresponds to the hyperenhancement seen on the contrast-enhanced ultrasonography. D-G: Immunohistochemical findings of the papillary tumor show MUC1 negativity (D), MUC2 positivity in less than 5% of the cells (E), MUC5AC positivity (F), and MUC6 positivity (G). The black bar in B represents 1000 µm, C represents 200 µm, and D-G represents 50 µm. MUC: Mucin core protein.](WJG-25-5569-g006){#F6}

FINAL DIAGNOSIS
===============

The final diagnosis of the presented neoplasm was cystic type IPNB with no invasion.

OUTCOME AND FOLLOW-UP
=====================

The patient was followed up for 25 mo after surgical resection, and there was no recurrence. Biannual follow-up examinations with several imaging modalities, including CT, MRI, and CEUS, are scheduled to be performed.

DISCUSSION
==========

Papillary growth of the liver neoplastic epithelium was first reported by Chen et al\[[@B4]\]. IPNB was described as a papillary neoplastic lesion of the biliary tract in the 2010 World Health Organization classification\[[@B5]\]. Both intra- and extrahepatic bile ducts can be a source of IPNB\[[@B6]\]. Intrahepatic IPNB is characterized into 3 types: Ductectatic-type, cystic-type, and diffuse-type neoplasms\[[@B7],[@B8]\]. Cystic-type IPNB often shares similar imaging features with cystic hepatic tumors, which may be misdiagnosed as mucinous cystic neoplasms, complicated hepatic cysts, cystic hemangiomas, lymphangiomas, hepatic foregut cysts, mesenchymal hematomas or teratomas\[[@B9]-[@B11]\]. Thus, careful follow-up and appropriate inspection of cystic hepatic tumors are necessary.

The diagnosis of a cystic hepatic tumor requires a comprehensive assessment by multiple imaging modalities. Kim et al\[[@B12]\] reported the CT criteria differentiating IPNB from simple hepatic cysts. The criteria included 4 CT findings: coexistence of fewer than 3 other cysts; transient hepatic attenuation differences; upstream bile duct dilatation; and lesion located in the left lobe. In the present case, only the number of cysts met the criteria, indicating that the present IPNB is atypical.

Ultrasonography is a more powerful imaging modality than CT or MRI for evaluating cystic hepatic lesions\[[@B13],[@B14]\]. Hyperenhancement of the cystic wall or nodules on CEUS is an important finding for evaluating the potential for malignancy\[[@B15]\]. Liu et al\[[@B16]\] investigated the imaging features of IPNB, and observed hyperenhancement during the arterial phase of CEUS in 60% of IPNB patients\[[@B16]\]. Tominaga et al\[[@B17]\] demonstrated that the hyperenhancement detected on CEUS corresponds with malignant tissue. Because the present case demonstrates that hyperenhancement observed on CEUS corresponds with microscopically extended dysplastic epithelia, hyperenhancement during the arterial phase of CEUS is an effective imaging feature for analyzing IPNB extension.

Pathological findings, especially regarding mucus secretion and the im-munohistochemistry of mucin core proteins, have been well-studied in the previous literature. Although most IPMNs have mucus hypersecretion, only 35% of IPNBs have a mucus hypersecretion phenotype\[[@B18]\]. The immunohistochemical results of mucin in IPNB are described as follows: MUC2 expression is common in the intestinal type, MUC6 is common in the gastric type, and MUC5AC is expressed in both of the phenotypes. As the presented case shows gastric epithelium, the MUC staining results are consistent with the phenotype. MUC1 is positive only in malignant IPNBs, such as pancreato-biliary and oncocytic type neoplasms\[[@B7],[@B11]\]. The lack of mucus secretion corresponds with MUC1 positivity and the malignant potential\[[@B19]\]. Downregulation of MUC1 protein expression decreases the metastatic potential of adenocarcinoma\[[@B20]\]. These previous findings support the clinical course of the present case, which progressed slowly and was not highly malignant.

Distinguishing cystic-type IPNB that develops on the small bile ducts from simple hepatic cysts is often difficult because the imaging features of these two neoplasms are similar\[[@B21]\]. We searched the English-language literature published after 2010 for IPNBs developed from cystic hepatic tumors that were followed up for more than one year before treatment. Five cases, including the present case, were treated by surgical resection (Table [1](#T1){ref-type="table"})\[[@B9],[@B22]-[@B24]\]. The follow-up period ranged from 2.5 to 13 years, and 4 patients showed gradual enlargement of the cystic tumor, initially without any clinical symptoms. Two patients developed clinical symptoms, but the other 3 did not, which indicates that most IPNBs show slow, asymptomatic progression. All patients were from East Asia: 4 were from Japan, and 1 was from South Korea. Tan et al\[[@B11]\] reviewed previous studies of 354 IPNB patients, among whom, 52.8% were from Japan, and 19.5% were from Eastern countries, including China, South Korea and Taiwan, which indicates that IPNBs occur more commonly in the East Asian population than in other populations. There was no previous literature which could detect the tumor progression from the main lesion to other cysts or bile ducts using CEUS. The present case shows that even if the tumor is followed for over a decade, periodic imaging surveillance is necessary. CEUS is an effective imaging method which can detect the detailed features of IPNB.

###### 

Case reports of intraductal papillary neoplasm of the bile ducts followed up for more than one year before treatment

  **Case**      **Age (yr)**   **Sex**   **Initial tumor size**   **Follow-up duration**   **Treated tumor size**   **Clinical symptom**   **Intervention**
  ------------- -------------- --------- ------------------------ ------------------------ ------------------------ ---------------------- ----------------------------
  1\[[@B9]\]    64             M         30 mm                    6 years                  50 mm                    None                   Left lateral hepatectomy
  2\[[@B22]\]   70             F         50 mm                    11 years                 50 mm                    Obstructive jaundice   Left hepatic lobectomy
  3\[[@B23]\]   61             F         20 mm                    8 years                  40 mm                    Abdominal distension   Segment 3 subsegmentectomy
  4\[[@B24]\]   56             M         30 mm                    2.5 years                43 mm                    None                   Caudate lobectomy
  Present       65             M         18 mm                    13 years                 33 mm                    None                   Segment 8 subsegmentectomy

M: Male; F: Female.

CONCLUSION
==========

We encountered a patient with an IPNB that developed over 13 years, who had no recurrence for 25 mo after the complete surgical resection. The present case suggests that IPNB slowly and asymptomatically develops for a long time. Thus, periodical imaging surveillance is needed for cystic hepatic tumors even if the tumor seems benign. CEUS is a useful inspection tool for evaluating the tumor progression of cystic lesions.
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